GMP Manufacturing Services
Utilizing custom design and development
to achieve regulatory approval
ABL has a long and successful history as a CDMO providing contract development and GMP biomanufacturing services to the biotech and biopharmaceutical industry. Our primary focus is viral vector manufacturing and we operate GMP facilities in the U.S. and Europe to meet your global regulatory and redundancy requirements. ABL offers a comprehensive portfolio of effective design, development, production and testing services for a broad range of virus products.
The success of your novel product starts with ABL
ABL’s 30+ years of viral-vector development and GMP production accelerates your novel gene therapies, vaccines, oncolytics and immunotherapies.
30+
YEARS OF EXPERIENCE
200+
CLIENTS
250+
GMP LOTS
Viral Vector Manufacturing Experts
Our product types
We are a biomanufacturing corporation with global facilities, suites and production platforms focused on accelerating your life changing innovation to market
Experience producing numerous viral vectors for
Gene therapies | Vaccines | Oncolytics | Immunotherapies
HSV-1
Vaccinia
(and MVA)
VLPs
Zika
CMV
Lentivirus
(and Retrovirus)
Adenovirus
AAV
VSV
When developing life changing innovations,
the right strategic partner makes the difference
Comprehensive GMP Manufacturing Support
Process design
Process feasibility
Upstream and/or downstream process development
Assay development and qualification
Master and working cell and virus banks
Scale-up and engineering run(s)
GMP bulk drug substance
GMP aseptic fill/finish
Analytical lot release testing
ICH stability testing
Chemistry, manufactoring and controls support
Quality systems
ABL’s U.S. location adheres to Good Manufacturing Practice (GMP) standards and is ISO 9001 accredited. ABL Europe’s facilities are regularly inspected by the French regulatory authorities (ANSM) and is a GMP licensed site for the manufacture of drug substance and aseptically prepared small volume liquid (drug product) viral products in accordance with EMA regulations.
Global GMP Manufacturing Facility
Our U.S. facility is available for GMP production of clinical, pre-clinical trials, and commercial material with iCELLis 500+ platform ready for use. See our New Capabilities.
Learn about our biomanufacturing services
In addition to the services listed above, ask about our protein manufacturing and GMP antibody production services.
